Novel Rx
![](https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg)
2 years 8 months ago
Factors Associated with Poor Vaccine Response in Rituximab: Dr. Yuzaiful Yusof (@Yuz6Yusof) discusses abstract #0437 presented at the #ACR21 annual meeting.
https://t.co/T0PFiZlbTa https://t.co/idj5T7j7ke
![](https://pbs.twimg.com/media/FDy6lYmWEAAu4hL.jpg)
![](https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3.jpg)
2 years 8 months ago
Comparative risks of skin SCC and BCC with different DMARDs. Abatacept appeared worst, HR 2.18, but may be residual confounding due to burden disease/comorbidities. Abstr#1942 #ACR21 @RheumNow https://t.co/UzOwuKKFmX
![](https://pbs.twimg.com/media/FDi3LOxWQAIpyjj.jpg)
![](https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G.jpg)
2 years 8 months ago
Who declines most with #scleroderma #ILD - early dcSSc, ⬆️CRP, ⬆️mRSS all w more ⤵️FVC. Results verified in SENSIS trial of SSc ILD where #nintedanib was superior to placebo abst#1846 #ACR21 @RheumNow https://t.co/eckUj0qwch
![](https://pbs.twimg.com/media/FDx0kMmX0AQnRgd.jpg)
![](https://pbs.twimg.com/profile_images/1324821320429981703/dAiq_hpT.jpg)
2 years 8 months ago
Should we be measuring drug levels in pts taking infliximab?
⭐️Drug monitoring vs. standard dosing showed 73% sustained control vs. 55% (RA, PsA, SpA, UC, Crohn's, PsO)
#ACR21
Abs#1946
#ACRBest @RheumNow
https://t.co/sWMen50ljP https://t.co/F4Wpqis3id
![](https://pbs.twimg.com/media/FDwPR4sXoAA2Plz.jpg)
![](https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G.jpg)
2 years 8 months ago
OK is this a swan or a swan song? Graph looks like a swan 🦢 but message is NO #MACE differences in PsA on csDMARDs v #biologics #ACR21 abst#1833 @RheumNow https://t.co/TM91z5wiFY